Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve
Ricardo Palao, Jorge Aguilera-Sáez, Jordi Serracanta, Jose Manuel Collado, Bruce Patrik Dos Santos, Juan Pedro Barret, Plastic, Reconstructive and Burns Unit Service, Vall d’Hebron University Hospital, 08035 Barcelona, Spain
Author contributions: Palao R, Aguilera-Sáez J and Serracanta J designed and performed research; Palao R, Aguilera-Sáez J, Serracanta J, Collado JM, Dos Santos BP and Barret JP analysed de data; Palao R, Aguilera-Sáez J and Dos Santos BP wrote the paper.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Vall d’hebron University Hospital.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: The authors report no relevant conflicts of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Ricardo Palao, MD, Staff Member, Plastic, Reconstructive and Burns Unit Service, Vall d’Hebron University Hospital, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain. rpalao@vhebron.net
Telephone: +34-62-9330102
Received: August 23, 2016
Peer-review started: August 24, 2016
First decision: October 8, 2016
Revised: November 16, 2016
Accepted: January 20, 2017
Article in press: January 21, 2017
Published online: May 2, 2017
Peer-review started: August 24, 2016
First decision: October 8, 2016
Revised: November 16, 2016
Accepted: January 20, 2017
Article in press: January 21, 2017
Published online: May 2, 2017
Core Tip
Core tip: Burns continue to be a common injury in western countries. It is difficult to assess the severity of burns, but knowing its mechanisms as well as its characteristics can be of help. An alternative to surgical debridement is the enzymatic or chemical debridement, although past reports that used it with patients show that its efficiency is limited. Nexobrid® is a new enzymatic debridement agent. We show our learning curve with it.